W: decision granting a waiver in all age groups for all conditions or indications
Decision date
Decision
P/0367/2019: EMA decision of 8 November 2019 on the acceptance of a modification of an agreed paediatric investigation plan for daclatasvir (Daklinza), (EMEA-001191-PIP01-11-M03)